WO2009075582A3 - Particules acoustiquement sensibles administrant des médicaments comprenant des lipides formant des structures non lamellaires - Google Patents

Particules acoustiquement sensibles administrant des médicaments comprenant des lipides formant des structures non lamellaires Download PDF

Info

Publication number
WO2009075582A3
WO2009075582A3 PCT/NO2008/000437 NO2008000437W WO2009075582A3 WO 2009075582 A3 WO2009075582 A3 WO 2009075582A3 NO 2008000437 W NO2008000437 W NO 2008000437W WO 2009075582 A3 WO2009075582 A3 WO 2009075582A3
Authority
WO
WIPO (PCT)
Prior art keywords
forming lipids
drug delivery
sensitive drug
acoustically sensitive
delivery particles
Prior art date
Application number
PCT/NO2008/000437
Other languages
English (en)
Other versions
WO2009075582A2 (fr
WO2009075582A4 (fr
Inventor
Cecilia Leal Lauten
Karen Sibylla Rognvaldsson
Sigrid L. Fossheim
Esben A. Nilssen
Tove J. Evjen
Original Assignee
Epitarget As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitarget As filed Critical Epitarget As
Priority to EP08858597A priority Critical patent/EP2222279A2/fr
Priority to JP2010537884A priority patent/JP2011506432A/ja
Priority to US12/747,123 priority patent/US8765172B2/en
Publication of WO2009075582A2 publication Critical patent/WO2009075582A2/fr
Publication of WO2009075582A3 publication Critical patent/WO2009075582A3/fr
Publication of WO2009075582A4 publication Critical patent/WO2009075582A4/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles particules acoustiquement sensibles transportant des médicaments comprenant des lipides formant des structures non lamellaires. L'invention concerne également leurs utilisations et leurs procédés. Les particules transportant des médicaments s'accumulent dans les tissus cibles malades et libèrent efficacement leur charge utile après exposition à une énergie acoustique.
PCT/NO2008/000437 2007-12-10 2008-12-09 Particules acoustiquement sensibles administrant des médicaments comprenant des lipides formant des structures non lamellaires WO2009075582A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP08858597A EP2222279A2 (fr) 2007-12-10 2008-12-09 Particules acoustiquement sensibles administrant des médicaments comprenant des lipides formant des structures non lamellaires
JP2010537884A JP2011506432A (ja) 2007-12-10 2008-12-09 非ラメラ形成脂質を含む音響感受性薬物送達粒子
US12/747,123 US8765172B2 (en) 2007-12-10 2008-12-09 Acoustically sensitive drug delivery particles comprising non-lamellar forming lipids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
NO20076380 2007-12-10
NO20076380 2007-12-10
NO20082900 2008-06-26
NO20082900 2008-06-26

Publications (3)

Publication Number Publication Date
WO2009075582A2 WO2009075582A2 (fr) 2009-06-18
WO2009075582A3 true WO2009075582A3 (fr) 2010-08-12
WO2009075582A4 WO2009075582A4 (fr) 2010-10-14

Family

ID=40445655

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NO2008/000437 WO2009075582A2 (fr) 2007-12-10 2008-12-09 Particules acoustiquement sensibles administrant des médicaments comprenant des lipides formant des structures non lamellaires

Country Status (4)

Country Link
US (1) US8765172B2 (fr)
EP (1) EP2222279A2 (fr)
JP (1) JP2011506432A (fr)
WO (1) WO2009075582A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2440176A2 (fr) * 2009-06-08 2012-04-18 Epitarget AS Particules d'administration de médicament acoustiquement sensibles comprenant de faibles concentrations de phosphatidyléthanolamine
US20120148663A1 (en) * 2009-06-08 2012-06-14 Epitarget As Lipophilic drug carrier
WO2010143972A2 (fr) * 2009-06-08 2010-12-16 Epitarget As Particules sensibles à l'énergie pour l'administration de médicament comprenant des lipides formant une structure non lamellaire
US9034374B2 (en) * 2009-06-08 2015-05-19 Ic Targets As Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine
US20120288557A1 (en) 2009-12-22 2012-11-15 Epitarget As Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
WO2013129936A1 (fr) 2012-02-27 2013-09-06 Epitarget As Utilisation d'un anticorps et d'un immunomodulateur particulaire en thérapie
WO2013129935A1 (fr) * 2012-02-27 2013-09-06 Epitarget As Utilisation d'un immunomodulateur particulaire en cancérothérapie
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
CN110302394A (zh) * 2013-11-22 2019-10-08 国立大学法人东京大学 药物递送用载体、偶联物及含有这些成分的组合物以及它们的施予方法
US20230263905A1 (en) 2020-04-29 2023-08-24 Imgt Co, Ltd. Sonosensitive liposome and method for preparing same
JPWO2022030646A1 (fr) * 2020-08-07 2022-02-10

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999039738A1 (fr) * 1998-02-09 1999-08-12 Bracco Research S.A. Apport cible de milieux biologiquement actifs
WO2002078445A1 (fr) * 2001-03-29 2002-10-10 The Scripps Research Institute Formulations comprenant des ingredients actifs pieges et utilisations de ces formulations
US20060002994A1 (en) * 2004-03-23 2006-01-05 Thomas James L Responsive liposomes for ultrasonic drug delivery
US20060159738A1 (en) * 2004-12-14 2006-07-20 Applera Corporation Cationic liposomes and methods of use
EP1884232A1 (fr) * 2005-05-23 2008-02-06 Mebiopharm Co., Ltd. Procede de production de liposomes renfermant du gaz
WO2008120998A2 (fr) * 2007-03-30 2008-10-09 Epitarget As Particules administrant des médicaments acoustiquement sensibles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5947921A (en) * 1995-12-18 1999-09-07 Massachusetts Institute Of Technology Chemical and physical enhancers and ultrasound for transdermal drug delivery
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
EP1328254B1 (fr) * 2000-10-25 2007-02-21 The University Of British Columbia Formulations de lipides pour une administration ciblee
WO2007102481A1 (fr) * 2006-03-07 2007-09-13 National University Corporation Hokkaido University Vecteur pour le transport nucléaire d'une substance

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999039738A1 (fr) * 1998-02-09 1999-08-12 Bracco Research S.A. Apport cible de milieux biologiquement actifs
WO2002078445A1 (fr) * 2001-03-29 2002-10-10 The Scripps Research Institute Formulations comprenant des ingredients actifs pieges et utilisations de ces formulations
US20060002994A1 (en) * 2004-03-23 2006-01-05 Thomas James L Responsive liposomes for ultrasonic drug delivery
US20060159738A1 (en) * 2004-12-14 2006-07-20 Applera Corporation Cationic liposomes and methods of use
EP1884232A1 (fr) * 2005-05-23 2008-02-06 Mebiopharm Co., Ltd. Procede de production de liposomes renfermant du gaz
WO2008120998A2 (fr) * 2007-03-30 2008-10-09 Epitarget As Particules administrant des médicaments acoustiquement sensibles

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Egg PC, L-alpha-phosphatidylcholine, (Egg, Chicken)", XP002568855, Retrieved from the Internet <URL:http://avantilipids.com/index.php?option=com_content&view=article&id=260&Itemid=212&catnumber=840051> [retrieved on 20100211] *
FERIL L B ET AL: "Ultrasound enhances liposome-mediated gene transfection", ULTRASONICS: SONOCHEMISTRY, BUTTERWORTH-HEINEMANN, GB, vol. 12, no. 6, 1 August 2005 (2005-08-01), pages 489 - 493, XP004857720, ISSN: 1350-4177 *
HUANG S-L ET AL: "Acoustically active liposomes for drug encapsulation and ultrasound-triggered release", BIOCHIMICA ET BIOPHYSICA ACTA. BIOMEMBRANES, AMSTERDAM, NL, vol. 1665, no. 1-2, 11 October 2004 (2004-10-11), pages 134 - 141, XP004592242, ISSN: 0005-2736 *
LIN HUNG-YIN ET AL: "PEG-Lipids and Oligo(ethylene glycol) Surfactants Enhance the Ultrasonic Permeabilizability of Liposomes", LANGMUIR, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 19, 1 January 2003 (2003-01-01), pages 1098 - 1105, XP002479875, ISSN: 0743-7463, [retrieved on 20030124] *
MYHR G ET AL: "Synergistic and tumour selective effects of chemotherapy and ultrasound treatment", CANCER LETTERS, NEW YORK, NY, US, vol. 232, no. 2, 8 February 2006 (2006-02-08), pages 206 - 213, XP025021894, ISSN: 0304-3835, [retrieved on 20060208] *
ROWE, R.C., SHESKEY, P.J., AND WELLER, P.J. (EDS): "Handbook of Pharmaceutical Excipients Fourth Edition", 2003, PHARMACEUTICAL PRESS AND AMERICAN PHARMACEUTICAL ASSOCIATION, London, ISBN: 0853694729, XP002568856 *

Also Published As

Publication number Publication date
US8765172B2 (en) 2014-07-01
WO2009075582A2 (fr) 2009-06-18
WO2009075582A4 (fr) 2010-10-14
US20110008416A1 (en) 2011-01-13
EP2222279A2 (fr) 2010-09-01
JP2011506432A (ja) 2011-03-03

Similar Documents

Publication Publication Date Title
WO2009075582A3 (fr) Particules acoustiquement sensibles administrant des médicaments comprenant des lipides formant des structures non lamellaires
WO2010143969A3 (fr) Particules d&#39;administration de médicament présentant une sensibilité acoustique comprenant de la phosphatidyléthanolamine formant des structures non lamellaires
WO2008120998A3 (fr) Particules administrant des médicaments acoustiquement sensibles
HK1200332A1 (en) Highly concentrated drug particles, formulations, suspensions and uses thereof
USD629890S1 (en) Pant diaper
WO2008118587A3 (fr) Applications thérapeutiques des cellules présentant un antigène humain par l&#39;intermédiaire de la dectine.-1
WO2010141417A3 (fr) Systèmes et méthodes d&#39;altération de la fonction du tissu du muscle lisse
WO2008105773A3 (fr) Système pour l&#39;administration ciblée d&#39;agents thérapeutiques
WO2011157741A3 (fr) Conjugués anticorps humain-médicament contre le facteur tissulaire
IL212856A (en) Human antibodies against human tissue factor, conjugates and their use
UA108598C2 (xx) Високоефективні кон&#39;югати та гідрофільні зшиваючі агенти (лінкери)
IL219876A (en) Antibodies against human 1h-7b or its fragment, preparations containing them and their use in the preparation of drugs
EP2271300A4 (fr) Embouchure de thérapie à impulsion d&#39;air de déglutition et son procédé d&#39;utilisation
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
IL202376A (en) History of pyridazinone, drugs and their kit containing and use
WO2008036206A3 (fr) Dispositifs médicaux implantables à base de composite copolymère-biocéramique
TWI372621B (en) Water-soluble iron-carbohydrate derivative complexes, the preparation thereof, and medicaments comprising them
PL2230932T3 (pl) Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym
IL208336A (en) Pyridazinone derivatives, drugs containing them and their uses and process for preparation
ZA201002307B (en) Quinazolinedione derivatives,preparation thereof and therapeutic uses thereof
WO2009129387A3 (fr) Lipides cationiques et utilisations associees
WO2010143970A3 (fr) Particules d&#39;administration de médicament présentant une sensibilité acoustique comprenant de la phosphatidylcholine formant des structures non lamellaires
IL211864A0 (en) Amino subtitiuted benzoyl derivatives, methods for their preparation and their use in the preparation of anti-virus drugs
WO2011143118A3 (fr) Formulations résistantes à l&#39;alcool
AU2007270125A8 (en) Preservation and controlled delivery/release of spermatozoa

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08858597

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2010537884

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 4549/DELNP/2010

Country of ref document: IN

REEP Request for entry into the european phase

Ref document number: 2008858597

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008858597

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12747123

Country of ref document: US